Bipartisan legislation efforts build against PBMs

The latest stories trending on MedCity News.

Editor's Pick

Top Story Bipartisan Legislation Efforts Build Against PBMs A bipartisan group of House representatives introduced the Drug Price Transparency in Medicaid Act on Friday. The bill would ban spread pricing in Medicaid programs. Save $600 with Spring Networking Madness We're ready for spring, are you? In our enthusiasm for spring, we're bringing you a special limited time discount of $600 to attend INVEST, the premier healthcare networking event of 2023. Offer Ends 3/26 - Register Now!

Featured News

BioNTech Puts Up $200M to Partner With OncoC4 in Cancer Immunotherapy BioNTech is expanding its cancer immunotherapy scope by partnering with OncoC4 on clinical testing of its lead drug. The antibody was designed to offer a safety edge over other CTLA-4-blocking drugs it's on track for a Phase 3 test in non-small cell lung cancer. Healthcare Moves: A Monthly Summary of Hires and Layoffs Here is a selection of recent executive hires, promotions and layoffs occurring across the healthcare industry. Zus Health Snags $40M, Strikes Partnership with Elation Health Zus Health — Jonathan Bush's health data platform that provides patient information at the point of care — recently closed a $40 million funding round. It also announced a partnership with Elation Health, a company that sells its EHR and other technology solutions to primary care providers. Elation will be integrating Zus' API into its own data collaboration systems. MedArrive, Ouma Strike Partnership To Bring Maternal Care to Medicaid Members Through a new partnership, MedArrive can now connect its Medicaid patients to Ouma's maternal care services. When MedArrive's providers visit patients' homes, they screen for patients' needs and will connect them to Ouma if they determine the patients require maternal health support. How Patient Engagement Systems Move Patient Care Forward and Benefit Staff New technologies thoughtfully implemented help providers reallocate time and deliver new value by aligning efforts with provider goals to enhance the experience for patients. Leveraging these new digital solutions allows clinicians to streamline lower-priority and non-clinical tasks, so they're able to focus on bedside patient care. Takeda Details the Clinical Data That Led to a $4B Deal for an Autoimmune Drug Takeda Pharmaceutical drug TAK-279 achieved the main goal of a mid-stage clinical trial in plaque psoriasis, setting the stage for Phase 3. The Japanese pharmaceutical giant sees the small molecule as complementary to its top-selling product, the blockbuster inflammatory bowel disorder drug Entyvio, and competitive against Bristol Myers Squibb's Sotyktu. An Innovative Return on Investment Methodology that is Honest and Reliable In healthcare, we need honest methodologies that accurately capture both the cost and complexity of specialty care and deliver a reliable ROI calculation. Only this sort of replicable, high-integrity ROI calculation can truly associate accessing high quality specialists with lower cost and better outcomes amidst today's healthcare access and affordability crisis. The Covid-19 Pandemic Has Served as a Catalyst for Diagnostic Transformation The Covid-19 pandemic has transformed the way we think of diagnostics in our daily lives. In a recent webinar, BD Vice President for Diagnostics Nikos Pavlidis spoke with a clinician and an epidemiologist where they shared their perspectives on how testing developments have changed the way we track respiratory illnesses.

Resources

How Top Health Plans Use AI to Save Money and Work Smarter Learn how an AI-powered solution helped Blue Cross Blue Shield of Rhode Island target members within its congestive heart failure (CHF) and spinal care (MSK) programs to identify avoidable hospitalizations and drive significant cost savings. Download Now

MedCity News • 611 Broadway • New York, NY unsubscribe